サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1577505

医療情報の世界市場

Medical Information

出版日
ページ情報
英文 270 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療情報の世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 270 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療情報の世界市場は2030年までに41億米ドルに達する見込み

2023年に28億米ドルと推定される医療情報の世界市場は、2023年から2030年にかけてCAGR 5.4%で成長し、2030年には41億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるインハウスサービスは、CAGR 5.0%を記録し、分析期間終了時には23億米ドルに達すると予測されます。請負アウトソーシングサービスセグメントの成長率は、分析期間中CAGR 5.9%と推定されます。

米国市場は推定7億6,660万米ドル、中国はCAGR8.6％で成長予測

米国の医療情報市場は、2023年に7億6,660万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億4,390万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と5.5%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の医療情報市場- 主要動向と促進要因のまとめ

医療情報はどのように進化してきたか？

医療情報は過去数十年の間に劇的な変貌を遂げ、ファイリングキャビネットで管理される紙ベースの記録から、世界中のどこからでもリアルタイムでアクセスできる高度な電子カルテ（EHR）へと進化しました。かつては、ヘルスケア・プロバイダー間での患者データの共有は、しばしば時間がかかり非効率的で、断片的なケアにつながっていました。しかし、デジタル・ソリューションの出現により、医療情報はより合理化され、アクセスしやすくなり、ヘルスケア全体の質が向上しました。このシフトは、より良い患者転帰、データ・セキュリティ、規制遵守に対する要求の高まりによって推進されています。さらに、医療提供者も患者も、モバイルヘルス（mヘルス）アプリケーション、ウェアラブル、遠隔医療を取り入れ、遠隔で健康状態を監視・管理するようになっています。これらの進歩により、より個別化された治療が行われるようになり、個々の患者のニーズに合わせた治療を行う上でデータが重要な役割を果たすようになった。このような進化は、患者とヘルスケア提供者の間のギャップを埋める上で、テクノロジーがいかに重要となっているかを浮き彫りにしています。

今日、医療情報が直面している倫理とプライバシーの課題とは？

デジタル医療情報の否定できない利点にもかかわらず、データプライバシーとセキュリティに関する重大な懸念が続いています。サイバー攻撃やデータ漏洩の増加により、患者もヘルスケアプロバイダーも、機密性の高い医療情報が悪用される可能性にさらされています。最も差し迫った倫理的問題の1つは、データ共有と患者の守秘義務のバランスに関わるものです。共同ケアや共同研究を促進するために、より多くのデータがネットワーク上で共有されるようになるにつれ、患者の同意が適切に得られ、患者のデータが安全に保たれることを保証する必要性が高まっています。米国の「医療保険の相互運用性と説明責任に関する法律（HIPAA）」や欧州の「一般データ保護規則（GDPR）」といった規制の枠組みは、医療データの取り扱い方法について厳格なガイドラインを定めています。しかし、これらの規制は地域によって大きく異なるため、医療情報セキュリティの世界標準を作ることは困難です。さらに、人工知能（AI）や機械学習アルゴリズムを使用して医療データを分析することで、意思決定における潜在的な偏りや、これらのシステムの透明性に関する議論が巻き起こっています。テクノロジーが進化し続ける中、こうした倫理やプライバシーの課題に対処することは、ヘルスケアシステムに対する信頼を維持する上で最も重要です。

医療情報へのアクセスの変革においてテクノロジーが果たす役割とは？

テクノロジーは、医療情報へのアクセス、共有、利用方法を変革する最前線にあります。ビッグデータ解析の台頭により、ヘルスケアプロバイダーは膨大な医療データを解析してパターンを検出し、健康状態を予測することができるようになりました。クラウド・コンピューティングの統合により、医療機関は医療記録を安全に保管しアクセスできるようになり、同時にオンプレミスの保管システムに関連するコストを削減できるようになった。さらに、遠隔医療プラットフォームや患者ポータルによって、患者は自分の健康をよりコントロールできるようになり、カルテへのアクセス、医療提供者とのコミュニケーション、さらにはオンライン予約までできるようになった。診断ツールにおけるAIの利用もまた、診断の正確さとスピードを高め、人為的ミスの可能性を減らし、ヘルスケア提供者がより多くの情報に基づいた判断を下すことを可能にしています。スマートウォッチやフィットネストラッカーなどのウェアラブルデバイスは、患者のバイタルサインの継続的なモニタリングを可能にし、健康問題の早期発見やよりタイムリーな介入につながっています。ヘルスケアシステムのデジタル化が進むにつれて、テクノロジーは間違いなく医療情報のアクセシビリティと質の両方を向上させる上でさらに大きな役割を果たすと思われます。

医療情報市場の成長促進要因は？

医療情報市場の成長にはいくつかの要因がありますが、その多くは技術の進歩と消費者行動の変化に直結しています。まず、世界中のヘルスケア施設でEHRシステムの導入が進んでいるため、信頼性と拡張性に優れたデジタルソリューションに対する需要が高まっています。ヘルスケアプロバイダーが複数のプラットフォームや医療機関で患者情報を共有するシームレスな方法を求めているため、異なるシステム間の相互運用性の必要性も重要な促進要因となっています。さらに、慢性疾患の蔓延が進むにつれて、より頻繁で包括的な患者モニタリングが必要となり、遠隔モニタリング機器やmヘルスアプリケーションに対する需要の急増につながっています。消費者の行動も変化しており、患者はより便利でデジタル優先のヘルスケア体験をますます期待するようになっています。これが遠隔医療サービスの急成長を促しました。デジタルヘルスを推進する政府の取り組みや、ヘルスケアにおけるデータ主導の意思決定の必要性も、市場の拡大に寄与しています。最後に、AIと機械学習の医療情報システムへの統合は、予測分析と診断精度を高め、患者データをより効果的に管理する最先端のツールを医療提供者に提供することで、市場の成長をさらに促進しています。

調査対象企業の例（注目の36社）

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24030

Global Medical Information Market to Reach US$4.1 Billion by 2030

The global market for Medical Information estimated at US$2.8 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. In-House Services, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Contract Outsourcing Services segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$766.6 Million While China is Forecast to Grow at 8.6% CAGR

The Medical Information market in the U.S. is estimated at US$766.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$843.9 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Medical Information Market - Key Trends and Drivers Summarized

How Has Medical Information Evolved Over Time?

Medical information has undergone a dramatic transformation over the last few decades, evolving from paper-based records maintained in filing cabinets to sophisticated electronic health records (EHRs) that can be accessed in real-time from anywhere in the world. In the past, the sharing of patient data between healthcare providers was often slow and inefficient, leading to fragmented care. However, with the advent of digital solutions, medical information is now more streamlined and accessible, enhancing the overall quality of healthcare. This shift has been driven by the increasing demand for better patient outcomes, data security, and regulatory compliance. In addition, healthcare providers and patients alike are now embracing mobile health (mHealth) applications, wearables, and telemedicine to monitor and manage health conditions remotely. These advancements have resulted in more personalized care, with data playing a crucial role in tailoring treatments to individual patients' needs, thus moving the medical landscape toward more proactive and preventive care approaches. This evolution highlights how crucial technology has become in bridging the gap between patients and healthcare providers.

What Are the Ethical and Privacy Challenges Facing Medical Information Today?

Despite the undeniable benefits of digital medical information, significant concerns about data privacy and security persist. The rise of cyber-attacks and data breaches has left both patients and healthcare providers vulnerable to the potential misuse of sensitive medical information. One of the most pressing ethical issues involves the balance between data sharing and patient confidentiality. As more data is shared across networks to facilitate collaborative care and research, there is a growing need to ensure that patient consent is properly obtained, and their data remains secure. Regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe, have set strict guidelines on how medical data should be handled. However, these regulations vary significantly across regions, making it difficult to create a global standard for medical information security. Additionally, the use of artificial intelligence (AI) and machine learning algorithms to analyze medical data has sparked debates about potential biases in decision-making and the transparency of these systems. As technology continues to evolve, addressing these ethical and privacy challenges will be paramount to maintaining trust in the healthcare system.

What Role Does Technology Play in Transforming Access to Medical Information?

Technology is at the forefront of revolutionizing how medical information is accessed, shared, and utilized. The rise of big data analytics has enabled healthcare providers to analyze vast amounts of medical data to detect patterns and predict health outcomes, thus improving the overall efficiency of the healthcare system. The integration of cloud computing has further enabled healthcare organizations to store and access medical records securely while reducing the costs associated with on-premise storage systems. Furthermore, telemedicine platforms and patient portals have empowered patients to take more control of their health, allowing them to access their medical records, communicate with their healthcare providers, and even schedule appointments online. The use of AI in diagnostic tools is also enhancing the accuracy and speed of diagnosis, reducing the chances of human error and enabling healthcare providers to make more informed decisions. Wearable devices, such as smartwatches and fitness trackers, are allowing for continuous monitoring of patients’ vital signs, leading to early detection of health issues and more timely interventions. As the healthcare system continues to digitize, technology will undoubtedly play an even greater role in improving both the accessibility and quality of medical information.

What Are the Growth Drivers in the Medical Information Market?

The growth in the medical information market is driven by several factors, many of which are directly linked to technological advancements and changing consumer behavior. First, the increasing adoption of EHR systems across healthcare facilities worldwide has created a massive demand for reliable and scalable digital solutions. The need for interoperability between different systems is another key driver, as healthcare providers seek seamless ways to share patient information across multiple platforms and institutions. Additionally, the growing prevalence of chronic diseases has necessitated more frequent and comprehensive patient monitoring, leading to a surge in demand for remote monitoring devices and mHealth applications. Consumer behavior has also shifted, with patients increasingly expecting more convenient, digital-first healthcare experiences. This has driven the rapid growth of telemedicine services. Government initiatives promoting digital health and the need for data-driven decision-making in healthcare are also contributing to the expansion of the market. Lastly, the integration of AI and machine learning into medical information systems is enhancing predictive analytics and diagnostic accuracy, further fueling market growth by providing healthcare providers with cutting-edge tools to manage patient data more effectively.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Medical Information - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Timely Healthcare Data Propels Growth in the Medical Information Market
    • Increasing Focus on Patient-Centered Care Expands Addressable Market for Personalized Medical Information Solutions
    • Technological Advancements in Electronic Health Records (EHR) Drive Innovation in Medical Information Systems
    • Growing Use of AI and Machine Learning in Data Analysis Strengthens the Business Case for Medical Information Management
    • Rising Adoption of Telemedicine and Digital Health Platforms Spurs Demand for Real-Time Medical Information Access
    • Increasing Use of Mobile Health (mHealth) Apps Propels Growth in Consumer Access to Medical Information
    • Innovations in Blockchain for Secure Data Sharing Drive Trust in Medical Information Platforms
    • Here's How the Expansion of Health Information Exchanges (HIEs) Accelerates the Interoperability of Medical Information Systems
    • Surging Demand for Clinical Decision Support Systems (CDSS) Drives Growth in Medical Information Integration
    • Advancements in Wearable Devices and IoT Propel Growth in the Real-Time Medical Information Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Information Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Contract Outsourcing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Medical Device Manufacturers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION